Redi.Health collaborates with Labcorp to seamlessly connect patients and providers

COLUMBUS, O.H., July 12, 2022 — Today, Redi.Health, provider of health management technology that improves total patient health, is announcing a collaboration with Labcorp, a leading global life sciences company. Through this combined effort, Labcorp Drug Development’s Patient Access Solutions will integrate Redi.Health’s digital support platform to offer patients and their care providers a variety of digital and traditional communications channels and tools with real-time data synching to help patients better manage their health.

Labcorp forms strategic partnership with MD Anderson Cancer Center Foundation Spain to increase access to early phase oncology clinical trials

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 11, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced it has formed a strategic partnership with MD Anderson Cancer Center Foundation Spain, a non-profit organization whose objectives are to beat cancer and to increase accessibility of early phase oncology clinical trials.

Labcorp first national laboratory to offer monkeypox test

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 6, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced it will begin testing for monkeypox using the U.S. Centers for Disease Control and Prevention’s ( CDC ) orthopoxvirus test, which detects all non-smallpox related orthopoxviruses, including monkeypox.